CD24 and metabolic syndrome: compared CD24+/+ and CD24-/- littermate mice for their development of metabolic disorders, including obesity, dyslipidemia, insulin resistance, and nonalcoholic steatohepatitis (NASH) in response to high-fat feed diet and aging (12).